Fresenius Medical Care AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All FME.DE news ›Fresenius Medical Care at ASN Kidney Week 2026
As the world's leading nephrology meeting, the American Society of Nephrology’s (ASN) Kidney Week 2026 brings together kidney care professionals, researchers, and industry leaders from around the globe to share knowledge, explore the…
Innovation in healthcare roundup: Tandem Health, Pharmacy2U, Fresenius Medical Care
Healthtech company Tandem Health has signed an agreement with Pharmaceutical Press, acting on behalf of the BNF Partnership, to integrate the British National Formulary (BNF) and BNF for Children (BNFC) into its regulated AI Clinical…
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Gets Price Target Cut from Truist Financial
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) had its price target lowered by investment analysts at Truist Financial from $25.00 to $24.00 in a research report issued on Monday, Benzinga reports. The firm currently has…
Fresenius Medical Care AG : Release of a capital market information
Fresenius Medical Care AG / Disclosure pursuant to Art. 5 para. 1 lit. b) of Regulation (EU) No. 596/2014 Fresenius Medical Care AG : Release of a capital market information 12.10.2026 / 16:37 CET/CEST Fresenius Medical Care AG: Share…
Fresenius Medical Care appoints Shervin Korangy as new CEO
Shervin Korangy will succeed Helen Giza as the dialysis company prepares for its next phase of growth and innovation. Fresenius Medical Care appoints Shervin Korangy as new CEO Congress is weighing potential fixes to the No Surprises Act…
Fresenius Medical Care Names New CEO
Fresenius Medical Care appointed Shervin Korangy as its new chief executive officer. The German healthcare company said Wednesday that Korangy will succeed Helen Giza, effective Oct. 12. ... Fresenius Medical Care AG Healthcare Facilities…
Fresenius Medical Care replaces CEO, stock under pressure
Published on 10/08/2026 at 05:23 am EDT The stock fell 1.8 percent to 36.73 after already closing nearly seven percent lower the previous evening, when FMC announced the change. The shares have now returned to their early-June level. Both…
Fresenius Medical Care AG Announces CEO Changes
Published on 10/07/2026 at 11:28 am EDT He holds a Bachelor of Science in Economics with concentrations in Management and Finance from the Wharton School of the University of Pennsylvania. Fresenius Medical Care: Q2 beat overshadowed by…
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Under Ms. Giza's leadership, FME successfully optimized its portfolio and implemented the FME25+ transformation program, reshaping its organization, streamlining processes and reducing its cost base by around EUR 1.2 billion. These…
Fresenius Medical Care: Margin Expansion Supports The Story, But Growth Remains Limited
Fresenius Medical Care is improving operationally, with Q2 2026 organic revenue up 5% and adjusted operating profit up 23%. Read why FMS stock is a hold. - Fresenius Medical Care AG is improving operationally, with Q2 2026 organic revenue…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com20
-
tradingview.com5
-
seekingalpha.com2
-
marketbeat.com1
-
modernhealthcare.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.